Metabolism-related long non-coding RNAs (lncRNAs) as potential biomarkers for predicting risk of recurrence in breast cancer patients

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Januškevičienė I, Petrikaitė V. Heterogeneity of breast cancer: the importance of interaction between different tumor cell populations. Life Sci. 2019;239:117009.
   PubMed Web of Science ®Google Scholar
• Yousefi H, Maheronnaghsh M, Molaei F, et al. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance. Oncogene. 2020;39(5):953–974.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21(11):1253–1261.
   PubMed Web of Science ®Google Scholar
• Sanchez Calle A, Kawamura Y, Yamamoto Y, et al. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109(7):2093–2100.
   PubMed Web of Science ®Google Scholar
• Russo F, Fiscon G, Conte F, et al. Interplay between long noncoding RNAs and MicroRNAs in cancer. Methods Mol Biol. 2018;1819:75–92.
   PubMedGoogle Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–358.
   PubMed Web of Science ®Google Scholar
• Fiscon G, Paci P, Iannello G. MONSTER v1.1: a tool to extract and search for RNA non-branching structures. BMC Genomics. 2015;16(S6):S1.
   PubMedGoogle Scholar
• Liang Y, Song X, Li Y, et al. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis. Mol Cancer. 2020;19(1):85.
   PubMed Web of Science ®Google Scholar
• Jin Y, Zhang M, Duan R, et al. Long noncoding RNA FGF14-AS2 inhibits breast cancer metastasis by regulating the miR-370-3p/FGF14 axis. Cell Death Discov. 2020;6(1):103.
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27–47.
   PubMed Web of Science ®Google Scholar
• Lien EC, Lyssiotis CA, Cantley LC. Metabolic reprogramming by the PI3K-Akt-mTOR pathway in cancer. Recent Results Cancer Res. 2016;207:39–72.
   PubMedGoogle Scholar
• Camarda R, Williams J, Goga A. In vivo reprogramming of cancer metabolism by MYC. Front Cell Dev Biol. 2017;5:35.
   PubMed Web of Science ®Google Scholar
• Gaglio D, Bonanomi M, Valtorta S, et al. Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling. Cancer Metab. 2020;8(1):22.
   PubMed Web of Science ®Google Scholar
• Koobotse M, Holly J, Perks C. Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines. Oncotarget. 2018;9(71):33562–33576.
   PubMedGoogle Scholar
• Wickramasekera NT, Das GM. Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication. Mitochondrion. 2014;16:26–37.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu ZX, Wu QN, et al. Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming. Nat Commun. 2020;11(1):1507.
   PubMed Web of Science ®Google Scholar
• Deng SJ, Chen HY, Zeng Z, et al. Nutrient stress-dysregulated antisense lncRNA GLS-AS impairs GLS-mediated metabolism and represses pancreatic cancer progression. Cancer Res. 2019;79(7):1398–1412.
   PubMed Web of Science ®Google Scholar
• Hong W, Liang L, Gu Y, et al. Immune-related lncRNA to construct novel signature and predict the immune landscape of human hepatocellular carcinoma. Mol Ther Nucleic Acids. 2020;22:937–947.
   PubMedGoogle Scholar
• Zhang Y, Zhang L, Xu Y, et al. Immune-related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma. J Cell Physiol. 2020;235(12):9304–9316.
   PubMed Web of Science ®Google Scholar
• Simon N, Friedman J, Hastie T, et al. Regularization paths for cox’s proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1–13.
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36.
   PubMed Web of Science ®Google Scholar
• Arnedos M, Soria JC, Andre F, et al. Personalized treatments of cancer patients: a reality in daily practice, a costly dream or a shared vision of the future from the oncology community? Cancer Treat Rev. 2014;40(10):1192–1198.
   PubMed Web of Science ®Google Scholar
• Gandhi N, Das GM. Metabolic reprogramming in breast cancer and its therapeutic implications. Cells. 2019;2:89.
   PubMed Web of Science ®Google Scholar
• Dias AS, Almeida CR, Helguero LA, et al. Metabolic crosstalk in the breast cancer microenvironment. Eur J Cancer. 1990;2019(121):154–171.
   Google Scholar
• Ye Q, Han X, Wu Z. Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment. Bioengineered. 2020;11(1):1280–1300.
   PubMed Web of Science ®Google Scholar
• Ma F, Liu X, Zhou S, et al. Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop. Cancer Lett. 2019;450:63–75.
   PubMed Web of Science ®Google Scholar
• Du Y, Wei N, Ma R, et al. Long noncoding RNA MIR210HG promotes the warburg effect and tumor growth by enhancing HIF-1α translation in triple-negative breast cancer. Front Oncol. 2020;10:580176.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao Z, Liu W, et al. SNHG3 functions as miRNA sponge to promote breast cancer cells growth through the metabolic reprogramming. Appl Biochem Biotechnol. 2020;191(3):1084–1099.
   PubMed Web of Science ®Google Scholar
• Zhang L, Fu Y, Guo H. c-myc-induced long non-coding RNA small nucleolar rna host gene 7 regulates glycolysis in breast cancer. J Breast Cancer. 2019;22(4):533–547.
   PubMed Web of Science ®Google Scholar
• Xing Z, Zhang Y, Liang K, et al. Expression of long noncoding RNA YIYA promotes glycolysis in breast cancer. Cancer Res. 2018;78(16):4524–4532.
   PubMed Web of Science ®Google Scholar
• Lai J, Chen B, Zhang G, et al. Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature. J Transl Med. 2020;18(1):416.
   PubMed Web of Science ®Google Scholar
• Zhuang H, Huang S, Zhou Z, et al. A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer. Cancer Cell Int. 2020;20(1):493.
   PubMed Web of Science ®Google Scholar
• Rivadeneira DB, Delgoffe GM. Antitumor T-cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy. Clin Cancer Res off J Am Assoc Cancer Res. 2018;24(11):2473–2481.
   PubMed Web of Science ®Google Scholar
• Shevchenko I, Bazhin AV. Metabolic checkpoints: Novel avenues for immunotherapy of cancer. Front Immunol. 2018;9:1816.
   PubMed Web of Science ®Google Scholar
• Bai J, Yao B, Wang L, et al. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p. J Cell Biochem. 2019;120(6):10310–10322.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou W, Ma S, et al. Identification of a glycolysis-related LncRNA signature to predict survival in diffuse glioma patients. Front Oncol. 2020;10:597877.
   PubMed Web of Science ®Google Scholar
• Huang P, Xue J. Long non‑coding RNA FOXD2‑AS1 regulates the tumorigenesis and progression of breast cancer via the S100 calcium binding protein A1/Hippo signaling pathway. Int J Mol Med. 2020;46:1477–1489.
   PubMed Web of Science ®Google Scholar
• Jiang M, Qiu N, Xia H, et al. Long non‑coding RNA FOXD2‑AS1/miR‑150‑5p/PFN2 axis regulates breast cancer malignancy and tumorigenesis. Int J Oncol. 2019;54:1043–1052.
   PubMed Web of Science ®Google Scholar
• Li S, Zhang Y, Dong J, et al. LINC00893 inhibits papillary thyroid cancer by suppressing AKT pathway via stabilizing PTEN. Cancer Biomark. 2021;30(3):277–286.
   PubMed Web of Science ®Google Scholar